Offer - Urjas Oil for just ₹ 1 X
Olmeglare is a prescription drug, available for use as Tablet. It is primarily used for the treatment of High BP. The alternative uses of Olmeglare have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Olmeglare. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
The side effects typically associated with Olmeglare include Upper respiratory tract infection. While these are the most often observed Olmeglare side effects, there are can be others also. These have been listed below. Normally, these side effects of Olmeglare are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Olmeglare's effect is Severe during pregnancy and Mild for lactating mothers. In addition, Olmeglare's effects on the liver, heart and kidney are discussed below in the Olmeglare related warnings section.
Olmeglare is not recommended if you suffer from certain medical conditions as it can have adverse effects. Bradycardia (Slow Heart Rate), Low Blood Pressure (Hypotension) are examples of such conditions. Some other conditions that can be affected by Olmeglare are listed in the contraindications section below.
Drug reaction of Olmeglare with other medicines has been reported. See below for a complete list.
In addition to these precautions, you may also note that Olmeglare is not safe while driving, and is is not addictive in nature.
Olmeglare is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Olmeglare safe for pregnant women?
Pregnant women may get severe side effects after taking Olmeglare. If you are pregnant, do not take Olmeglare without a doctor's advice.
Is the use of Olmeglare safe during breastfeeding?
Olmeglare has been seen to have minimal side effects on breastfeeding women.
What is the effect of Olmeglare on the Kidneys?
Olmeglare has very mild side effects on the kidneys.
What is the effect of Olmeglare on the Liver?
Olmeglare may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Olmeglare on the Heart?
Olmeglare is rarely harmful for the heart.
Olmeglare should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Olmeglare unless your doctor advises you to do so -
Is this Olmeglare habit forming or addictive?
Olmeglare does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
After taking Olmeglare, you should not drive or work on any heavy machine, as Olmeglare can make you drowsy.
Is it safe?
Yes, but consume Olmeglare only on doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Olmeglare for mental disorders.
Interaction between Food and Olmeglare
Some foods when eaten with Olmeglare can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Olmeglare
Consuming Olmeglare with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173